Sclerifuma 240 mg (Dimethyl fumarate)

Sclerifuma 240 mg (Dimethyl fumarate) is an oral medication indicated for the management of relapsing forms of multiple sclerosis (MS). Dimethyl fumarate works by activating the Nrf2 pathway, which provides antioxidant and anti-inflammatory effects, protecting nerve cells from damage.

Regular use of Sclerifuma can help reduce the frequency of MS relapses, slow the progression of disability, and improve overall quality of life for patients. It is typically administered in a twice-daily dosing regimen and should be used under medical supervision.

Important Notes:

• May cause flushing, gastrointestinal discomfort, or mild nausea initially.

• Blood counts and liver function may require periodic monitoring.

• Not recommended during pregnancy unless clearly necessary.

Sclerifuma 240 mg is a trusted option for long-term management of multiple sclerosis, helping patients maintain daily activity and reduce disease progression.